|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 425.80 INR | +1.28% |
|
+3.31% | +37.31% |
| 05-27 | SMS Pharmaceuticals Limited, Q4 2026 Earnings Call, May 27, 2026 | |
| 05-22 | SMS Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| Market Cap | 35.11B 368M 322M 297M 276M 523M 530M 3.55B 1.38B 17.23B 1.38B 1.35B 59.75B | P/E 2024 |
30.3x | P/E 2025 | 27.3x |
|---|---|---|---|---|---|
| Enterprise Value | 37.8B 396M 347M 320M 297M 563M 571M 3.83B 1.49B 18.55B 1.49B 1.46B 64.33B | EV / Sales 2024 |
2.47x | EV / Sales 2025 | 2.75x |
| Free-Float |
25.48% | Yield 2024 |
0.22% | Yield 2025 | 0.19% |
Last Transcript: SMS Pharmaceuticals Limited
| 1 day | +1.38% | ||
| 1 week | +3.31% | ||
| Current month | +3.31% | ||
| 1 month | +15.56% | ||
| 3 months | +9.27% | ||
| 6 months | +23.54% | ||
| Current year | +37.31% |
| 1 week | 405.25 |  | 438.3 |
| 1 month | 363.25 | | 438.3 |
| Current year | 293.15 | | 447.8 |
| 1 year | 207.99 | | 447.8 |
| 3 years | 91.75 | | 447.8 |
| 5 years | 54.55 | | 447.8 |
| 10 years | 24 | | 447.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 30/08/1990 | |
| Director of Finance/CFO | - | 13/09/2017 | |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 30/08/1990 | |
| Director/Board Member | 37 | 05/06/2020 | |
| Director/Board Member | 48 | 29/05/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.28% | +3.31% | +75.79% | +354.13% | 413M | |
| +0.17% | +2.75% | +13.92% | +84.77% | 48.11B | |
| -0.47% | +7.50% | +72.56% | +122.68% | 37.88B | |
| -0.42% | +0.05% | -2.94% | +43.64% | 12.47B | |
| +1.18% | +4.40% | +16.29% | +99.48% | 12B | |
| 0.00% | +2.76% | +34.19% | +120.25% | 9.03B | |
| +0.90% | +1.91% | +20.83% | +47.75% | 7.24B | |
| +0.69% | +3.29% | +56.60% | -2.39% | 7.09B | |
| -0.62% | +21.06% | -16.02% | +24.43% | 6.54B | |
| +0.35% | +3.33% | +22.46% | +230.48% | 6.72B | |
| Average | +0.29% | +5.96% | +29.37% | +112.52% | 14.75B | |
| Weighted average by Cap. | +0.00% | +4.51% | +30.61% | +93.11% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7.09B 74.36M 65.12M 59.98M 55.67M 106M 107M 718M 279M 3.48B 279M 273M 12.07B | 7.83B 82.06M 71.87M 66.19M 61.44M 117M 118M 792M 308M 3.84B 308M 301M 13.32B |
| Net income | 498M 5.22M 4.57M 4.21M 3.91M 7.43M 7.53M 50.44M 19.63M 245M 19.62M 19.19M 848M | 691M 7.25M 6.35M 5.85M 5.43M 10.31M 10.44M 69.99M 27.24M 339M 27.22M 26.62M 1.18B |
| Net Debt | 2.45B 25.65M 22.46M 20.69M 19.2M 36.47M 36.96M 248M 96.38M 1.2B 96.32M 94.21M 4.16B | 2.69B 28.23M 24.72M 22.77M 21.14M 40.14M 40.68M 273M 106M 1.32B 106M 104M 4.58B |
Employees
1,470
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/07/26 | ₹425.80 | +1.28% | 220,886 |
| 06/07/26 | ₹420.40 | -0.25% | 132,284 |
| 03/07/26 | ₹421.45 | +0.91% | 174,002 |
| 02/07/26 | ₹417.65 | +2.13% | 370,094 |
| 01/07/26 | ₹408.95 | -0.87% | 1,654,483 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SMSPHARMA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
